The IARC Perspective on Cervical Cancer Screening

Véronique Bouvard(Centre international de recherche sur le cancer), Béatrice Lauby-Secretan(American Cancer Society), Johannes Berkhof(Amsterdam University Medical Centers), Robert A. Smith(American Cancer Society), Marta del Pino(American Cancer Society), Rachel Kupets(American Cancer Society), Silvina Arrossi(Center for the Study of State and Society), Blanca I. Indave Ruiz(American Cancer Society), Isabel Mosquera-Metcalfe(American Cancer Society), Zvavahera M. Chirenje(Global Brain Health Institute), Paolo Giorgi Rossi(Albert Einstein College of Medicine), Fanghui Zhao(Zhaotong University), Julia Brotherton(Canadian Institutes of Health Research), Michael H. Chung(American Cancer Society), Karen Canfell(Cancer Australia), Marc Arbyn(Ghent University), Suleeporn Sangrajrang(National Cancer Institute of Thailand), Mark Schiffman(National Institutes of Health), Nicolas Wentzensen(National Cancer Institute), Mona Saraiya(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rengaswamy Sankaranarayanan(Centre International de Recherche sur le Cancer), C. Simon Herrington(Edinburgh Cancer Research), Walter Prendiville(American Cancer Society), Raúl Murillo(American Cancer Society), F F Hamers(American Cancer Society), Chisato Hamashima(American Cancer Society), Miriam Elfström(Karolinska University Hospital), Eduardo L. Franco(McGill University), Silvia de Sanjosé(Unknown), Karima Bendahhou(American Cancer Society), Anne Mackie(American Cancer Society)
Obstetrical & Gynecological Survey
March 1, 2022
Cited by 10


Related Papers